Cellular uptake of antisense oligonucleotides

A M Tari1, G Lopez-Berestein

  • 1Department of Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston 77030, USA. atari@mdanderson.org

Current Opinion in Investigational Drugs (London, England : 2000)
|March 14, 2002
PubMed

Insights

Antisense oligonucleotides (AS ONs) block protein production by targeting mRNA. This review examines cell receptors involved in AS ON uptake and their bioavailability after in vivo administration.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Antisense oligonucleotides (AS ONs) are short nucleic acid sequences designed to inhibit gene expression by binding to target messenger RNA (mRNA).
  • Cellular uptake of AS ONs is primarily mediated by endocytosis, a process involving specific cell surface receptors.
  • The efficiency and specificity of AS ON delivery depend heavily on the type and expression levels of these receptors, which vary significantly across different cell types.

Purpose of the Study:

  • To review the characteristics of various cell surface receptors involved in the in vitro uptake of antisense oligonucleotides.
  • To discuss the mechanisms of receptor-mediated endocytosis for AS ONs.
  • To explore the bioavailability and cellular uptake of AS ONs following in vivo administration.

Main Methods:

  • Literature review of in vitro studies characterizing receptors involved in AS ON cellular uptake.
  • Analysis of data on receptor expression patterns in different cell types.
  • Review of studies investigating AS ON bioavailability and tissue distribution in vivo.

Main Results:

  • Identification and characterization of diverse cell surface receptors mediating AS ON endocytosis.
  • Demonstration that receptor characteristics and expression levels are cell-type specific, influencing AS ON uptake.
  • Overview of factors affecting AS ON bioavailability and cellular penetration in vivo.

Conclusions:

  • Receptor-mediated endocytosis is a critical pathway for cellular delivery of antisense oligonucleotides.
  • Understanding receptor characteristics is essential for optimizing AS ON delivery and therapeutic efficacy.
  • Further research into receptor-ligand interactions can enhance the development of targeted AS ON therapies.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...